Home
Janux Therapeutics

Janux Therapeutics Market Share Analysis for August 2026

Read the terms of use for Janux Therapeutics, a clinical-stage biopharmaceutical company developing a broad pipeline of novel T cell immunotherapies

Health > Biotechnology and Pharmaceuticals

Domainjanuxrx.com

Year Founded2017

Employees51 - 200

Annual Revenue$10M - $15M

Janux Therapeutics

Janux Therapeutics (including company regionals)

januxrx.com

See more website traffic and engagement information

Janux Therapeutics Revenue up to August 2026 is 10M - 15M

revenue generated by Janux Therapeutics top domains

Janux Therapeutics top domains revenue over 3 years

Revenue for Janux Therapeutics top domains

januxrx.com10M - 15M

See more with Sales Intelligence

Total visits to Janux Therapeutics's top domains

Understand Janux Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

januxrx.com4.8K

See more with Sales Intelligence

Avg. visit duration in Janux Therapeutics's top domains

Analyze Janux Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

januxrx.com00:00:47

See more with Sales Intelligence

Avg. pageviews on Janux Therapeutics's top domains

See how Janux Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

januxrx.com2.15

See more with Sales Intelligence

Janux Therapeutics top competitors by domain

Top similar sites in August 2026, ranked by their affinity

clinicaltrials.govCompany NameClinicalTrials.govEmployees201 - 500HQUnited States, North Carolina, DurhamAnnual revenue$15M - $25MTotal visits3MHealth > Health - Other

Top technologies used by Janux Therapeutics

These are the website technologies, by industry, used by Janux Therapeutics top domains

Payment & Currencies (10)

Cart Functionality

eCommerce (5)

OpenCart

Widget (4)

Twemoji

Conversion & Analytics (3)

Google Analytics

More Technologies

11

See all

News & Signals from Janux Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsJanux Therapeutics, Inc. had revenue of $10.3M on Aug 8th '26.* Janux Therapeutics missed quarterly expectations: The clinical-stage biotech reported a loss of $0.35 per share versus the consensus loss estimate of $0.25, while revenue of $10.27 million fell short of $19.07 million expected.

NewsJanux Therapeutics, Inc. launches "double-masked" T cell engager.Elsewhere, multiple biotechs are using OpenAI's "GPT-Rosalind" and Janux debuted a "double-masked" T cell engager.

NewsJanux Therapeutics, Inc. is developing cancer treatment on Jan 22nd '26.Janux Therapeutics said on January 22 that it has partnered with Bristol-Myers Squibb Company (NYSE:BMY) to develop a new cancer treatment, according to Reuters.